Program overview

13:00 onwards	Registration start - Check-In
13:30 - 16:30	Pre-Conference WORKSHOP “What Happens after Marriage - Managing Complex Alliances” Anthony A. Hörning, Strategic Transactions Advisory Did you ever wonder what happens after you have signed that licensing deal? Anthony A. Hörning, former Head of Alliance Management at Novartis Pharma, will share his insights regarding the ever-challenging implementation of complex collaborative deals. What makes them challenging? How to deal with decision-making and jointly solving problems in the context of differing perceptions? How do companies develop their alliance management maturity? Half the available time will be spent on a case study, in which participants will be engaged as if they were members of a Joint Development Committee. Newcomers to the Business Development and Licensing world, and all those who contribute to their companies' structuring, negotiating and implementing of collaborative license agreements, will find this a stimulating, interactive learning session. The number of attendees is limited to 30 maximum; please register early.
16:00 - 17:00	Welcome & Networking
17:00 - 17:30	Welcome & Opening of the 27^th Swiss HLG Winter Conference 2018 Gabrielle Gache, President Swiss HLG
17:30 - 18:15	Opening Keynote: Acquisition of Actelion by Johnson & Johnson: a unique deal Jean-Paul Clozel (Founder of Actelion Ltd) Chief Executive Officer, Idorsia Pharmaceuticals Ltd Jean-Paul sold the company Actelion he built to J&J in one of Switzerland biggest M&A transactions. We look forward to hear his thoughts on the strategic dimension of partnering and learn more about his new venture, Idorsia.
18:15 - 19:00	Deal Making in Biotech Venture Capital Francesco De Rubertis, Founder and Managing Partner, Medicxi
19:00 - 21:30	Kick-off Dinner & Networking
21:30 onwards	Meet your Peers at the fire place, Drinks offered by Swiss HLG

Monday, January 29^th 2018

08:00 - 08:30	Late registrations
08:30 - 08:45	Welcome & Houskeeping Kim Bill, Board Member Swiss HLG
08:45 - 09:45	Personal Development Session: "Design Thinking" Rana Lonnen, Head S&E Strategic Venture Capital, Novartis Pharma
09:45 - 11:45*	PARTNERING STEP OUT OF THE BOX: PARTNERING IN OTHER INDUSTRIES
	Partnering in other Industries - Panel Discussion Moderator: Christoph Daniel Maier, Board Member Swiss HLG Carey Pepper, Vice President, Managing Director Global Licensing, Swarovski François Taverne, CEO, Hermès Cuirs Précieux Daniel Weston, General Counsel & Global Head of CSV, Nestlé Nespresso SA
11:45 - 13:00	FINDING THE RIGHT DEAL - Part 1
	Finding the right Deal – Broker or not Alan Selby, Executive Director, Torreya Partners
	Finding the right Deal - The Cultural Aspect Shigeo Taniuchi, Head of EMEA, Senior Corporate officer & Member of the Board, Santen Pharmaceutical
13:00 - 14:30	Lunch & Networking
14:30 - 17:45*	FINDING THE RIGHT DEAL - Part 2
	Finding the right Deal – The Emerging Market View Viren Mahurkar, Former Regional Director Business Development and Licensing Asia and Russia, Alcon Division
	Finding the right Deal – Divestments Emma Barton, Director Alliance and Integration Management, AstraZeneca
	Finding the right Deal – from a mid-size corporate VC Fund Tanja Dowe, Chief Executive Officer, Debiopharm Innovation Fund S.A.
	Finding the right Deal – M&A/Deals, Trends in the Bio-manufacturing industry Vikalp Mohan, Vice President Sales and Marketing, Celonic AG
18:00 - 18:30	GPP (small group) Laurence de Schoulepnikoff, Board Member Swiss HLG
18:30 onwards	Swiss HLG Winter Walk, followed by Apero and Dinner in Chalet Atmosphere
21:30 onwards	Meet your Peers at the fire place, Drinks offered by Swiss HLG

* including networking breaks

Tuesday, January 30^th 2018

08:30 - 09:00	Swiss HLG General Assembly - on invitation
09:00 - 09:10	Welcome & Houskeeping Chris Isler, Winter Conference Director, Board Member Swiss HLG
09:10 - 12:30*	PARTNERING BEYOND THE MOLECULE
	Partnering for Data Alexandra V. Eberhard, Managing Director EMEA Signals Analytics
	Partnering for Digital An untapped opportunity; is Pharma the boiling frog? Michael Meissner, Chief Technology Officer, Med Unit, Sanofi
	Partnering, Rare Disease Deals – More than Meets the Eye Ravi Sodha, Senior Director, Business Development, Actelion
	Closing Keynote A perspective of corporate venture's influence on startups in healthcare Jon Otterstatter, Chief Executive Officer, Preventice Solutions Group
	Closing Remarks Jean-Marc Séquier, Vice President Swiss HLG
12:30 onwards	Farewell Lunch & Networking

* including networking breaks